(Q47720845)

5 February 2018

title

Candida albicans colonization and ASCA in familial Crohn's disease (English)

1 reference

5 February 2018

1 reference

1 reference

15

1 reference

5 February 2018

Paul Rutgeerts

9

Paul Rutgeerts

1 reference

5 February 2018

Jean-Frédéric Colombel

17

Jean-Frédéric Colombel

1 reference

5 February 2018

Boualem Sendid

2

Boualem Sendid

1 reference

5 February 2018

Daniel Poulain

16

Daniel Poulain

1 reference

5 February 2018

Marie Joossens

3

Marie Joossens

1 reference

5 February 2018

Peggy Vandewalle-El Khoury

5

Peggy Vandewalle-El Khoury

1 reference

5 February 2018

Annie Standaert-Vitse

1

Annie Standaert-Vitse

1 reference

5 February 2018

Mathias Chamaillard

14

Mathias Chamaillard

1 reference

5 February 2018

Julien Branche

6

Julien Branche

1 reference

5 February 2018

Corinne Gower-Rousseau

10

Corinne Gower-Rousseau

1 reference

5 February 2018

Christian Libersa

11

Christian Libersa

1 reference

5 February 2018

Nadine François

4

Nadine François

1 reference

5 February 2018

author name string

Herbert Van Kruiningen

7

1 reference

5 February 2018

Thierry Jouault

8

1 reference

5 February 2018

Christel Neut

12

1 reference

5 February 2018

Franck Broly

13

1 reference

5 February 2018

language of work or name

English

0 references

publication date

26 May 2009

1 reference

5 February 2018

The American Journal of Gastroenterology

published in

1 reference

5 February 2018

volume

104

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

1745-1753

1 reference

5 February 2018

The fundamental basis of inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Serologic markers in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Mother to child transmission of anti-S cerevisiae mannan antibodies (ASCA) in non-IBD families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Environmental Factors in Familial Crohnʼs Disease in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Biological activities of naturally occurring antibodies reactive with Candida albicans mannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Mucosal flora in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

The impact of cigarette/tobacco smoking on oral candidosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Smoking and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Immune recognition. A new receptor for beta-glucans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Nucleotide oligomerization domain 2 (Nod2) is not involved in the pattern recognition of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

The IL23 axis plays a key role in the pathogenesis of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

An integrated model of the recognition of Candida albicans by the innate immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.225

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.225

1 reference

5 February 2018

1 reference

5 February 2018